The dental membrane and bone graft substitute market is estimated to be valued at US$ 1143.56 Mn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
The Dental Membrane And Bone Graft Substitute Market is estimated to Witness High Growth Owing To Trends name Increasing Demand for Dental Implants.
Dental membrane and bone graft substitutes are used during dental implant procedures and bone regeneration treatments. Membranes prevent soft tissues from growing into the bone graft site and allow new bone formation. Bone graft substitutes help create new bone tissue in dental procedures. The increasing number of dental implant procedures due to rising awareness about oral healthcare and growing geriatric population is expected to drive the demand for dental membranes and bone graft substitutes over the forecast period.
Market key trends:
The global dental membrane and bone graft substitute market is witnessing high growth owing to increasing demand for dental implants. Rising geriatric population suffering from oral diseases, increasing number of dental clinics, dental laboratories, rising awareness about cosmetic dental procedures, and improved reimbursement scenario are some key factors driving the demand for dental implants. According to the American College of Prosthodontists, nearly 45 million Americans are missing at least one tooth. Dental membranes and bone graft substitutes play a critical role during dental implant procedures in maintaining graft containment and new bone formation. Synthetic bone graft substitutes are increasingly being used owing to their osteoinductive and osteoconductive properties, off-the-shelf availability, and ability to reduce morbidity associated with autograft procedures. Development of advanced bioactive bone graft substitutes with customized 3D printable capabilities further presents lucrative growth opportunities in the market over the forecast period.
Threat of new entrants: Low barriers as technology and expertise required is high. Bargaining power of buyers: Moderate as alternative treatment options are available. Bargaining power of suppliers: High as raw material suppliers have control over pricing and quantity. Threat of new substitutes: Low as membrane and grafts have well established use in dental procedures. Competitive rivalry: Intense as key players compete on basis of quality, cost and innovation.
Strengths: Growing demand for dental procedures and high efficacy of products. Weaknesses: High costs associated and stringent regulatory norms. Opportunities: Untapped growth potential in developing regions and technological advancements. Threats: Threat from alternative treatment options and reimbursement issues.
The global Dental Membrane And Bone Graft Substitute Market is expected to witness high growth, exhibiting CAGR of 9.4% over the forecast period, due to increasing number of dental surgeries and product development. North America dominates the market currently owing to supportive reimbursement policies and developed healthcare infrastructure in the region. The Asia Pacific region is expected to be the fastest growing market due to rising dental issues and increasing dental healthcare expenditure.
Key players operating in the Dental Membrane And Bone Graft Substitute market are Zimmer Biomet, Geistlich Pharma North America Inc., ACE Surgical Supply Company, Inc., BioHorizons, LifeNet Health, RTI Surgical, Institut Straumann AG, Dentsply Sirona Inc., Citagenix, Inc., Orthogen AG, DentiumUSA, KaVo Dental, Danaher, BONESUPPORT AB, Cerapedics, Inc., Molecular Matrix, Inc., Medtronic, LASAK s.r.o., Collagen Matrix, Inc., and OrthoPediatrics Corp.